| 发明名称 |
Advanced Heart Failure Treatment Material as Myocardial/Cardiovascular Regeneration Device |
| 摘要 |
Provided is an advanced heart failure treatment material, as a myocardial/cardiovascular regeneration device, that self-assembles, which can improve the universality and be used in an emergency by commercialization with no need of cell-culturing (cell-free) by controlling stem cells, and has a high therapeutic effect on the fundamental treatment of intractable cardiovascular diseases, in particular, advanced heart failure, in which not only the saving of lives but also improving the patient's quality of life (QOL) are urgent issues. The advanced heart failure treatment material includes a pharmaceutical agent, an agent holding for the pharmaceutical agent, and a myocardial support device. |
| 申请公布号 |
US2015231312(A1) |
申请公布日期 |
2015.08.20 |
| 申请号 |
US201314429565 |
申请日期 |
2013.09.13 |
| 申请人 |
Osaka University ;Nipro Corporation ;Ono Pharmaceutical Co., Ltd. |
发明人 |
Sawa Yoshiki;Miyagawa Shigeru;Fukushima Satsuki;Saito Atsuhiro;Sakai Yoshiki;Matsuda Kazuhisa;Maruyama Takayuki |
| 分类号 |
A61L31/16;A61L31/14;A61K9/00;A61K9/16;A61K31/4406;A61K31/343 |
主分类号 |
A61L31/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An advanced heart failure treatment material comprising a pharmaceutical agent, an agent holding for the pharmaceutical agent, and a myocardial support device. |
| 地址 |
Suita-shi, Osaka JP |
